Reaction Details Report a problem with these data
Target
D(3) dopamine receptor
Ligand
BDBM571846
Substrate
n/a
Meas. Tech.
Binding Inhibition for Dopamine D3 Receptor
Ki
0.093±n/a nM
Citation
 Ichihashi, Y; Inagaki, M; Masuda, K Cyclic compound having dopamine D3 receptor antagonistic effect US Patent  US11447484 Publication Date 9/20/2022 
Target
Name:
D(3) dopamine receptor
Synonyms:
DRD3 | DRD3_HUMAN | Dopamine D3 receptor
Type:
PROTEIN
Mol. Mass.:
44213.40
Organism:
Homo sapiens
Description:
ChEMBL_105671
Residue:
400
Sequence:
MASLSQLSGHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC
  
Inhibitor
Name:
BDBM571846
Synonyms:
US11447484, Compound I-003
Type:
Small organic molecule
Emp. Form.:
C32H35FN4O2
Mol. Mass.:
526.6443
SMILES:
Fc1cccc(c1)-c1conc1C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2cccc3ncccc23)CC1 |r,wU:21.26,wD:18.19,(-3.06,3.94,;-4.52,4.42,;-4.84,5.92,;-6.31,6.4,;-7.45,5.37,;-7.13,3.86,;-5.67,3.39,;-8.28,2.83,;-9.78,3.15,;-10.55,1.82,;-9.52,.67,;-8.12,1.3,;-6.78,.53,;-6.78,-1.01,;-5.45,-1.78,;-4.12,-1.01,;-2.78,-1.78,;-1.45,-1.01,;-.11,-1.78,;-.11,-3.32,;1.22,-4.09,;2.55,-3.32,;2.55,-1.78,;1.22,-1.01,;3.89,-4.09,;5.22,-3.32,;5.22,-1.78,;6.55,-4.09,;6.55,-5.63,;7.89,-6.4,;9.22,-5.63,;9.22,-4.09,;10.55,-3.32,;10.55,-1.78,;9.22,-1.01,;7.89,-1.78,;7.89,-3.32,;-4.12,.53,;-5.45,1.3,)|
Structure:
Search PDB for entries with ligand similarity: